The largest database of trusted experimental protocols

Superdex 75 10 300 gl size exclusion chromatography column

Manufactured by GE Healthcare

The Superdex 75 10/300 GL is a size exclusion chromatography column used for the separation and purification of proteins, peptides, and other biomolecules based on their molecular size. It has a separation range of 3,000 to 70,000 daltons and a column volume of 24 mL. The column is packed with a stable, cross-linked agarose-dextran matrix and is designed for use with low- to medium-pressure liquid chromatography systems.

Automatically generated - may contain errors

6 protocols using superdex 75 10 300 gl size exclusion chromatography column

1

Characterization of SAA1-Retinol Binding to LRP1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Binding of SAA1 to the LRP1 ectodomain was confirmed by size exclusion chromatography. Purified SAA1 was incubated with retinol at a molar ratio of 1:1.5 at 4°C in the dark for 20 min to allow formation of the SAA1–retinol complex, followed by passage over a Superdex 75 10/300 GL size exclusion chromatography column (GE Healthcare) to remove the excess retinol. Next, the SAA1-retinol complex was mixed with the purified full-length ectodomain of LRP1 at a molar ratio of 10:1 in buffer containing 10 mM MES pH 5.5 and 100 mM NaCl. The mixture was incubated on ice for 1 hour and then loaded onto a Superose 6 increase 10/300 GL column (GE Healthcare). As controls, LRP1 ectodomain and SAA1–retinol were individually analyzed in the same way.
+ Open protocol
+ Expand
2

UbcH5B~Ubiquitin Conjugation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
UbcH5B~ubiquitin linkage was performed based on published methods21 (link). Briefly, Ube1, UbcH5B(S22R/C85K) and ubiquitin were mixed and buffer exchanged into 50 mM Tris pH 10, 150 mM NaCl using PD-10 desalting columns (GE Healthcare). 10 mM MgCl2, 5 mM ATP and 1 mM TCEP were added and the protein was incubated at 37°C for 16 h. The completeness of the reaction was monitored using SDS-PAGE and covalently linked UbcH5B~ubiquitin was purified from unreacted proteins and Ube1 using a Superdex 75 10/300 GL size exclusion chromatography column (GE Healthcare) equilibrated in protein buffer.
+ Open protocol
+ Expand
3

Purification and Characterization of His-Tagged Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 6xHis-SUMO-PBR and 6xHis-SUM-OPBR (R82A/R93A) mutant were purified and concentrated at 5 mg/mL in a buffer containing 20 mM Tris-HCl (pH 8) and 500 mM NaCl and injected into an AKTA protein purification system (GE Healthcare) connected to a Superdex 75 10/300 GL size exclusion chromatography column (GE Healthcare).
+ Open protocol
+ Expand
4

UbcH5B~Ubiquitin Conjugation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
UbcH5B~ubiquitin linkage was performed based on published methods21 (link). Briefly, Ube1, UbcH5B(S22R/C85K) and ubiquitin were mixed and buffer exchanged into 50 mM Tris pH 10, 150 mM NaCl using PD-10 desalting columns (GE Healthcare). 10 mM MgCl2, 5 mM ATP and 1 mM TCEP were added and the protein was incubated at 37°C for 16 h. The completeness of the reaction was monitored using SDS-PAGE and covalently linked UbcH5B~ubiquitin was purified from unreacted proteins and Ube1 using a Superdex 75 10/300 GL size exclusion chromatography column (GE Healthcare) equilibrated in protein buffer.
+ Open protocol
+ Expand
5

Stable Oxyester-linked UBCH5B-Ubiquitin Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
For experiments using oxyester-linked UBCH5B-ubiquitin complexes, an active site Cys-to-Ser mutation (C85S UBCH5B) was performed. The resulting bond was only one atom different from the wt thioester and significantly more stable. A successful conjugation reaction was typically accomplished by mixing 1 µM E1, 150–200 µM E2, 500–600 µM ubiquitin, cycling buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7), 10 mM creatine phosphate (Sigma-Aldrich), ~0.6 units mL−1 creatine kinase (Sigma-Aldrich), 5 mM MgCl2, and 5 mM ATP. Conjugation reactions were incubated at 37 °C for 16–20 h, and the reaction was monitored using SDS–PAGE. Oxyester linked UBCH5B-ubiquitin was purified from E1 and unreacted proteins using a Superdex® 75 10/300 GL size-exclusion chromatography column (GE Healthcare) equilibrated in 50 mM K2HPO4 and 50 mM KH2PO4 pH 7 [24 (link)]. The purified C85S UBCH5B–Ub conjugate was collected, flash-frozen in liquid nitrogen and stored at −80 °C.
+ Open protocol
+ Expand
6

Synthesis of Oxyester-linked UbcH5B-Ubiquitin Conjugates

Check if the same lab product or an alternative is used in the 5 most similar protocols
For experiments using oxyester-linked UbcH5B–ubiquitin complexes, an active site Cys-to-Ser mutation (UbcH5B C85S) was performed. The resulting bond was only one atom different from the wt thioester and significantly more stable. A successful conjugation reaction was typically accomplished by mixing 1 µM E1, 150–200 µM E2, 500–600 µM ubiquitin, cycling buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7), 10 mM creatine phosphate (Sigma-Aldrich), ~0.6 units mL−1 creatine kinase (Sigma-Aldrich), 5 mM MgCl2, and 5 mM Adenosine Triphosphate (ATP). Conjugation reactions were incubated at 37 °C for 16–20 h, and the completeness of the reaction was monitored using sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Oxyester-linked UbcH5B–ubiquitin was purified from E1 and unreacted proteins using a Superdex® 75 10/300 GL size-exclusion chromatography column (GE Healthcare) equilibrated in 50 mM K2HPO4 and 50 mM KH2PO4 pH 7 buffer. The purified C85S UBCH5B–Ub conjugate was collected, flash-frozen in liquid nitrogen, and stored at −80  °C. The same protocol was performed in the synthesis of C85S-S22R UbcH5B-Ub conjugate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!